左心室垂动脉瘤切除和副心替换用于垂高性心肌病变
Hironobu Nishiori1, Hiroyuki Watanabe1, Yuichi Hirano1
1Division of Cardiovascular Surgery Narita Red Cross Hospital Chiba Japan.
Clinical case reports
|October 2, 2023
概括
左心室缩性缩性心肌病与缩动脉瘤可以导致严重的并发症,如血栓和心房动. 手术干预,包括动脉瘤切除和门置换,是预防致命结果的可行选择.
科学领域:
- 心脏病学 心脏病学
- 心脏外科手术 心脏外科手术
背景情况:
- 左心室缩性心肌病 (ApHCM) 是一种以左心室顶部变厚为特征的疾病.
- 带有尾动脉瘤 (LVAA) 的ApHCM存在风险,包括血栓形成,心房动和功能性腹.
研究的目的:
- 介绍一个患有ApHCM和左心室垂动脉瘤 (LVAA) 的病例.
- 在这个背景下,讨论严重的心房功能性心肌反的管理.
- 评估手术干预在预防致命并发症方面的理由.
主要方法:
- 一名78岁的女性患者接受了手术治疗.
- 程序包括左心室垂动脉瘤 (LVAA) 切除和中枢置换.
主要成果:
- 这位患者患有严重的心房功能性心房回.
- 为了解决这些心脏疾病,进行了手术干预.
结论:
- 左心室垂动脉瘤切除与 mitra 置换相结合是一种合理的方法.
- 这种手术策略可以有效地预防与LVAA和ApHCM相关的潜在致命并发症.
相关概念视频
Cardiomyopathy III: Hypertrophic Cardiomyopathy
16
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
Cardiomyopathy V: Interprofessional Care
14
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14
Mitral Stenosis III: Medical Management
12
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
12
Mitral Regurgitation III: Medical Management
18
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
18
Mitral Valve Prolapse II: Assessment and Management
20
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
20
Mitral Stenosis I: Introduction
15
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
15


